Impact of a clinical audit and feedback strategy on the diagnosis of alpha-1 antitrypsin deficiency: A multicenter before-and-after clinical audit study

INTRODUCTION: Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that remains markedly underdiagnosed, despite international recommendations for systematic screening in all patients with chronic obstructive pulmonary disease (COPD). Strategies to improve adherence to guideline-recommended screening in real-world clinical practice are needed. The objective of our study was to evaluate the impact of a structured clinical audit and feedback program on AATD screening practices in patients with COPD in a real-world, multicenter setting. METHODS: We conducted a multicenter, before-and-after observational study based on two retrospective clinical audits performed in nine public hospitals in Western Andalusia (Spain). Patients >14 years, with COPD diagnosis were consecutively included. The intervention between audits consisted of audit-based feedback, including an educational meeting and periodic reminders. The primary outcomes were the proportion of patients undergoing serum alpha-1 antitrypsin (AAT) determination and rates of genetic testing. RESULTS: A total of 895 medical records were analyzed (452 in Audit 1 and 443 in Audit 2). Serum AAT determination increased significantly from 61.1% in the baseline audit to 71.3% in the re-audit (p = 0.00117), representing an absolute increase of 10.3 percentage points. Genetic testing increased from 3.1% to 5.0%, although this difference did not reach statistical significance. Among patients with AAT < 116 mg/dL, genetic testing increased from 44.0% to 50.0%. Genotype results were available for 33 of 36 patients in whom genetic testing was recommended, with M/Z, M/S, S/S, Z/Z, S/Mmalton, Z/Mmalton, and M/Plowell variants identified in addition to M/M genotypes. In the baseline audit, AAT testing was more frequent among patients followed in specialized COPD clinics. CONCLUSIONS: A pragmatic clinical audit and feedback strategy was associated with an increase in AATD screening among patients with COPD in routine clinical practice. However, substantial gaps remain in the completion of confirmatory genetic testing.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-16
DOI
https://doi.org/10.1371/journal.pone.0362750
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of a clinical audit and feedback strategy on the diagnosis of alpha-1 antitrypsin deficiency: A multicenter before-and-after clinical audit study

Cristina Carrasco, Francisco Luis Gil-Muñoz, Juan María Rubio, Ana Fulgencio et al.
1 links
PLoS ONE
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Impact of a clinical audit and feedback strategy on the diagnosis of alpha-1 antitrypsin deficiency: A multicenter before-and-after clinical audit study

Cristina Carrasco, Francisco Luis Gil-Muñoz, Juan María Rubio, Ana Fulgencio, Eva Vázquez-Gandullo, Virginia Almadana Pacheco, Brittany Sanchez, Alba Fernández-Boza, Carmen Cabrera, Antonio Requejo, Armando Falcés, Antonio José Ruiz Reina, José Luis López-Campos
article en

Abstract

INTRODUCTION: Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that remains markedly underdiagnosed, despite international recommendations for systematic screening in all patients with chronic obstructive pulmonary disease (COPD). Strategies to improve adherence to guideline-recommended screening in real-world clinical practice are needed. The objective of our study was to evaluate the impact of a structured clinical audit and feedback program on AATD screening practices in patients with COPD in a real-world, multicenter setting. METHODS: We conducted a multicenter, before-and-after observational study based on two retrospective clinical audits performed in nine public hospitals in Western Andalusia (Spain). Patients >14 years, with COPD diagnosis were consecutively included. The intervention between audits consisted of audit-based feedback, including an educational meeting and periodic reminders. The primary outcomes were the proportion of patients undergoing serum alpha-1 antitrypsin (AAT) determination and rates of genetic testing. RESULTS: A total of 895 medical records were analyzed (452 in Audit 1 and 443 in Audit 2). Serum AAT determination increased significantly from 61.1% in the baseline audit to 71.3% in the re-audit (p = 0.00117), representing an absolute increase of 10.3 percentage points. Genetic testing increased from 3.1% to 5.0%, although this difference did not reach statistical significance. Among patients with AAT < 116 mg/dL, genetic testing increased from 44.0% to 50.0%. Genotype results were available for 33 of 36 patients in whom genetic testing was recommended, with M/Z, M/S, S/S, Z/Z, S/Mmalton, Z/Mmalton, and M/Plowell variants identified in addition to M/M genotypes. In the baseline audit, AAT testing was more frequent among patients followed in specialized COPD clinics. CONCLUSIONS: A pragmatic clinical audit and feedback strategy was associated with an increase in AATD screening among patients with COPD in routine clinical practice. However, substantial gaps remain in the completion of confirmatory genetic testing.

PLoS ONEVol. 21(11)
Hospital Universitario Virgen Macarena (ES), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Hospital Universitario Reina Sofía (ES), Hospital Juan Ramón Jiménez (ES), Instituto de Biomedicina de Sevilla (ES), Hospital Universitario Puerto Real (ES), Hospital Universitario Puerta del Mar (ES), Hospital Universitario Virgen del Rocío (ES), Hospital de Montilla (ES), Hospital Universitario de Jerez (ES)
Grifols
Good health and well-being
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon